Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidyl...
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
ABSTRACT
There has been scarce research on the potential neuroprotective effects of remifentanil (REM) in septic individuals. We aimed to investigate the role and underlying mechanism of REM in LPS‐induced neuroinflammation. Thirty‐two rats were randomly divided to control, lipopolysaccharide (LPS), LPS + REM, and REM groups. Depending on the gr...
Alternative Titles
Full title
Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11788742
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11788742
Other Identifiers
ISSN
2052-1707
E-ISSN
2052-1707
DOI
10.1002/prp2.70071
